$11.3 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 85 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 69.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Buy | SPDR S&P 500 ETF TRput | $1,642,542,000 | +99.4% | 6,538,000 | +91.9% | 14.60% | +70.6% |
NXPI | Buy | NXP SEMICONDUCTORS N V | $873,620,000 | +24.2% | 7,725,000 | +20.2% | 7.76% | +6.3% |
TWX | Buy | TIME WARNER INC | $862,834,000 | +23.1% | 8,422,000 | +20.7% | 7.67% | +5.4% |
AABA | Sell | ALTABA INC | $802,992,000 | +18.6% | 12,122,457 | -2.5% | 7.14% | +1.5% |
BCR | Buy | BARD C R INC | $507,993,000 | +9.7% | 1,585,000 | +8.2% | 4.52% | -6.1% |
GOOG | Buy | ALPHABET INCcap stk cl c | $374,364,000 | +34.1% | 390,324 | +27.1% | 3.33% | +14.8% |
DVMT | Buy | DELL TECHNOLOGIES INC | $348,483,000 | +47.5% | 4,513,440 | +16.7% | 3.10% | +26.2% |
WAB | Buy | WABTEC CORP | $336,357,000 | +14.4% | 4,440,356 | +38.2% | 2.99% | -2.1% |
PLYA | PLAYA HOTELS & RESORTS NV | $319,230,000 | -12.7% | 30,606,930 | 0.0% | 2.84% | -25.3% | |
FB | Sell | FACEBOOK INCcl a | $316,789,000 | -9.1% | 1,853,979 | -19.7% | 2.82% | -22.2% |
Q | Sell | QUINTILES IMS HOLDINGS INC | $295,483,000 | -15.2% | 3,108,053 | -20.2% | 2.63% | -27.5% |
V | Sell | VISA INC | $248,752,000 | -6.1% | 2,363,668 | -16.3% | 2.21% | -19.6% |
CTXS | Buy | CITRIX SYS INC | $223,436,000 | +74.8% | 2,908,562 | +81.0% | 1.99% | +49.5% |
HDS | Sell | HD SUPPLY HLDGS INC | $196,010,000 | +4.1% | 5,434,168 | -11.6% | 1.74% | -10.9% |
MSFT | Buy | MICROSOFT CORP | $191,947,000 | +12.7% | 2,576,812 | +4.3% | 1.71% | -3.6% |
KITE | New | KITE PHARMA INC | $175,213,000 | – | 974,435 | +100.0% | 1.56% | – |
RDUS | Buy | RADIUS HEALTH INC | $151,744,000 | -9.0% | 3,936,300 | +6.8% | 1.35% | -22.1% |
BIIB | Buy | BIOGEN INC | $148,732,000 | +157.9% | 475,000 | +123.5% | 1.32% | +120.7% |
FIS | Buy | FIDELITY NATL INFORMATION SV | $147,051,000 | +14.7% | 1,574,586 | +4.9% | 1.31% | -1.9% |
INFO | Buy | IHS MARKIT LTD | $139,764,000 | +13.7% | 3,170,699 | +13.6% | 1.24% | -2.7% |
ALR | Sell | ALERE INC | $137,673,000 | -36.9% | 2,700,000 | -37.9% | 1.22% | -46.0% |
EFX | New | EQUIFAX INC | $136,727,000 | – | 1,290,000 | +100.0% | 1.22% | – |
VRSK | Buy | VERISK ANALYTICS INC | $136,083,000 | +234.1% | 1,635,807 | +238.8% | 1.21% | +186.1% |
STZ | Sell | CONSTELLATION BRANDS INCcl a | $130,614,000 | -3.8% | 654,869 | -6.6% | 1.16% | -17.7% |
VEON | Buy | VEON LTDsponsored adr | $123,032,000 | +54.0% | 29,433,518 | +44.0% | 1.09% | +31.8% |
TRU | New | TRANSUNION | $109,745,000 | – | 2,322,158 | +100.0% | 0.98% | – |
HERBALIFE LTDnote 2.000% 8/1 | $108,286,000 | -3.9% | 108,177,000 | 0.0% | 0.96% | -17.8% | ||
AZN | Buy | ASTRAZENECA PLCsponsored adr | $107,738,000 | +449.6% | 3,180,000 | +453.0% | 0.96% | +369.6% |
BUD | New | ANHEUSER BUSCH INBEV SA/NVsponsored adr | $107,370,000 | – | 900,000 | +100.0% | 0.95% | – |
LBTYA | Sell | LIBERTY GLOBAL PLC | $101,490,000 | -25.1% | 2,992,935 | -29.1% | 0.90% | -35.9% |
LBTYK | Sell | LIBERTY GLOBAL PLC | $101,036,000 | -25.6% | 3,089,773 | -29.0% | 0.90% | -36.3% |
HUN | Sell | HUNTSMAN CORP | $95,970,000 | -31.5% | 3,500,000 | -35.4% | 0.85% | -41.4% |
CPN | New | CALPINE CORP | $95,285,000 | – | 6,460,000 | +100.0% | 0.85% | – |
BMY | New | BRISTOL MYERS SQUIBB CO | $86,368,000 | – | 1,355,000 | +100.0% | 0.77% | – |
HLF | Sell | HERBALIFE LTD | $85,455,000 | -42.9% | 1,259,835 | -40.0% | 0.76% | -51.1% |
Sell | SOLARCITY CORPnote 1.625%11/0 | $78,148,000 | -42.4% | 82,332,000 | -42.5% | 0.70% | -50.7% | |
GILD | New | GILEAD SCIENCES INC | $76,564,000 | – | 945,000 | +100.0% | 0.68% | – |
FOLD | Buy | AMICUS THERAPEUTICS INC | $76,622,000 | +153.6% | 5,081,055 | +69.4% | 0.68% | +116.9% |
AKRXQ | New | AKORN INC | $75,673,000 | – | 2,280,000 | +100.0% | 0.67% | – |
CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $69,506,000 | -38.4% | 191,255 | -42.9% | 0.62% | -47.2% |
CMCSA | Sell | COMCAST CORP NEWcl a | $67,018,000 | -48.6% | 1,741,621 | -48.0% | 0.60% | -56.0% |
GNCMA | Buy | GENERAL COMMUNICATION INCcl a | $67,051,000 | +186.4% | 1,643,800 | +157.3% | 0.60% | +145.3% |
BRCD | New | BROCADE COMMUNICATIONS SYS I | $61,304,000 | – | 5,130,000 | +100.0% | 0.54% | – |
FGEN | Buy | FIBROGEN INC | $59,180,000 | +70.9% | 1,100,000 | +2.6% | 0.53% | +46.1% |
ABBV | Sell | ABBVIE INC | $51,983,000 | -14.1% | 585,000 | -29.9% | 0.46% | -26.6% |
ANTM | ANTHEM INC | $39,875,000 | +0.9% | 210,000 | 0.0% | 0.35% | -13.7% | |
SLD | SUTHERLAND ASSET MGMT CORP M | $36,491,000 | +5.7% | 2,324,236 | 0.0% | 0.32% | -9.5% | |
XLRN | New | ACCELERON PHARMA INC | $35,939,000 | – | 963,000 | +100.0% | 0.32% | – |
GRFS | Buy | GRIFOLS S Asp adr rep b nvt | $31,298,000 | +37.2% | 1,429,773 | +32.4% | 0.28% | +17.3% |
ESV | New | ENSCO PLC | $29,372,000 | – | 4,920,000 | +100.0% | 0.26% | – |
EXEL | Sell | EXELIXIS INC | $28,834,000 | -22.7% | 1,190,000 | -21.5% | 0.26% | -34.0% |
GLPG | New | GALAPAGOS NVspon adr | $24,035,000 | – | 236,216 | +100.0% | 0.21% | – |
IONS | New | IONIS PHARMACEUTICALS INC | $22,815,000 | – | 450,000 | +100.0% | 0.20% | – |
LUMN | New | CENTURYLINK INCput | $21,622,000 | – | 1,144,000 | +100.0% | 0.19% | – |
SVRA | SAVARA INC | $20,804,000 | +59.0% | 2,225,000 | 0.0% | 0.18% | +36.0% | |
RYAAY | Sell | RYANAIR HLDGS PLCsponsored adr ne | $20,597,000 | -19.9% | 195,382 | -18.2% | 0.18% | -31.5% |
SNI | New | SCRIPPS NETWORKS INTERACT IN | $20,184,000 | – | 235,000 | +100.0% | 0.18% | – |
SBAC | Sell | SBA COMMUNICATIONS CORP NEWcl a | $19,697,000 | -86.2% | 136,738 | -87.1% | 0.18% | -88.2% |
ENTA | New | ENANTA PHARMACEUTICALS INC | $19,297,000 | – | 412,333 | +100.0% | 0.17% | – |
MYOK | New | MYOKARDIA INC | $17,033,000 | – | 397,500 | +100.0% | 0.15% | – |
SPB | New | SPECTRUM BRANDS HLDGS INC | $15,570,000 | – | 147,000 | +100.0% | 0.14% | – |
HRG | New | HRG GROUP INC | $15,376,000 | – | 985,000 | +100.0% | 0.14% | – |
SAGE | Buy | SAGE THERAPEUTICS INC | $15,170,000 | +90.5% | 243,500 | +143.5% | 0.14% | +62.7% |
AKBA | AKEBIA THERAPEUTICS INC | $14,359,000 | +36.9% | 730,000 | 0.0% | 0.13% | +17.4% | |
RGNX | New | REGENXBIO INC | $13,740,000 | – | 417,000 | +100.0% | 0.12% | – |
STML | Buy | STEMLINE THERAPEUTICS INC | $13,181,000 | +23.8% | 1,187,500 | +2.6% | 0.12% | +5.4% |
ZEAL | New | ZEALAND PHARMA A Ssponsored adr | $12,480,000 | – | 650,000 | +100.0% | 0.11% | – |
ZGNX | Buy | ZOGENIX INC | $11,216,000 | +341.9% | 320,000 | +82.9% | 0.10% | +284.6% |
CLLS | New | CELLECTIS S Asponsored ads | $10,953,000 | – | 385,000 | +100.0% | 0.10% | – |
MON | Sell | MONSANTO CO NEW | $10,784,000 | -57.6% | 90,000 | -58.1% | 0.10% | -63.6% |
WGL | WGL HLDGS INC | $10,104,000 | +0.9% | 120,000 | 0.0% | 0.09% | -13.5% | |
CYOU | Buy | CHANGYOU COM LTDads rep cl a | $9,506,000 | +52.5% | 240,000 | +49.2% | 0.08% | +29.2% |
ANAB | New | ANAPTYSBIO INC | $8,598,000 | – | 246,000 | +100.0% | 0.08% | – |
NCNA | New | NUCANA PLCsponsored adr | $7,348,000 | – | 400,000 | +100.0% | 0.06% | – |
MRNS | New | MARINUS PHARMACEUTICALS INC | $6,868,000 | – | 1,170,000 | +100.0% | 0.06% | – |
Sell | SOLARCITY CORPnote 2.750%11/0 | $6,743,000 | -46.0% | 6,765,000 | -45.9% | 0.06% | -53.8% | |
IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $6,588,000 | – | 850,000 | +100.0% | 0.06% | – |
PCO | PENDRELL CORPcl a new | $5,608,000 | -5.5% | 821,061 | 0.0% | 0.05% | -19.4% | |
QCOM | QUALCOMM INC | $4,406,000 | -6.1% | 85,000 | 0.0% | 0.04% | -20.4% | |
VYGR | New | VOYAGER THERAPEUTICS INC | $3,452,000 | – | 167,665 | +100.0% | 0.03% | – |
BKD | BROOKDALE SR LIVING INC | $3,498,000 | -27.9% | 330,000 | 0.0% | 0.03% | -38.0% | |
GCVRZ | SANOFIright 12/31/2020 | $2,458,000 | -5.3% | 6,827,805 | 0.0% | 0.02% | -18.5% | |
KALA | New | KALA PHARMACEUTICALS INC | $2,284,000 | – | 100,000 | +100.0% | 0.02% | – |
DCPH | New | DECIPHERA PHARMACEUTICALS IN | $1,899,000 | – | 100,000 | +100.0% | 0.02% | – |
NITE | New | NIGHTSTAR THERAPEUTICS PLCadr | $774,000 | – | 40,300 | +100.0% | 0.01% | – |
TOCA | Exit | TOCAGEN INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
Exit | GNC HLDGS INCnote 1.500% 8/1 | $0 | – | -2,700,000 | -100.0% | -0.02% | – | |
IMGN | Exit | IMMUNOGEN INC | $0 | – | -505,000 | -100.0% | -0.04% | – |
AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -1,495,000 | -100.0% | -0.06% | – |
HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -745,000 | -100.0% | -0.09% | – |
TGNA | Exit | TEGNA INC | $0 | – | -670,000 | -100.0% | -0.10% | – |
KATE | Exit | KATE SPADE & CO | $0 | – | -530,000 | -100.0% | -0.10% | – |
RXDX | Exit | IGNYTA INC | $0 | – | -1,153,500 | -100.0% | -0.12% | – |
PTLA | Exit | PORTOLA PHARMACEUTICALS INCput | $0 | – | -250,000 | -100.0% | -0.15% | – |
H | Exit | HYATT HOTELS CORP | $0 | – | -265,000 | -100.0% | -0.16% | – |
ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.17% | – |
NVET | Exit | NEXVET BIOPHARMA PUB LTD CO | $0 | – | -2,648,696 | -100.0% | -0.18% | – |
SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -108,500 | -100.0% | -0.19% | – |
PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -213,000 | -100.0% | -0.19% | – |
AKAOQ | Exit | ACHAOGEN INC | $0 | – | -948,500 | -100.0% | -0.21% | – |
TRCO | Exit | TRIBUNE MEDIA COcl a | $0 | – | -735,000 | -100.0% | -0.31% | – |
CAB | Exit | CABELAS INC | $0 | – | -605,000 | -100.0% | -0.37% | – |
IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -4,227,500 | -100.0% | -0.39% | – |
WBMD | Exit | WEBMD HEALTH CORP | $0 | – | -679,130 | -100.0% | -0.41% | – |
HUM | Exit | HUMANA INC | $0 | – | -178,500 | -100.0% | -0.45% | – |
PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -855,000 | -100.0% | -0.50% | – |
NORD | Exit | NORD ANGLIA EDUCATION INC | $0 | – | -1,535,000 | -100.0% | -0.52% | – |
AGN | Exit | ALLERGAN PLC | $0 | – | -227,500 | -100.0% | -0.57% | – |
CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -610,000 | -100.0% | -0.59% | – |
TMH | Exit | TEAM HEALTH HOLDINGS INC | $0 | – | -2,298,900 | -100.0% | -1.09% | – |
MBBYF | Exit | MOBILEYE N V AMSTELVEEN | $0 | – | -5,907,500 | -100.0% | -3.85% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
GRIFOLS S A | 33 | Q4 2021 | 0.9% |
ALPHABET INC | 32 | Q3 2023 | 4.2% |
SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
VISA INC | 30 | Q3 2023 | 2.9% |
WABTEC CORP | 27 | Q3 2023 | 3.6% |
EXELIXIS INC | 27 | Q3 2023 | 2.8% |
ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
Solid Power, Inc. | February 11, 2022 | ? | ? |
Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR | 2024-02-14 |
13F-HR/A | 2024-02-12 |
SC 13G/A | 2024-02-01 |
SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.